Primary Graft Failure Following Lung Transplantation
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
STUDY OBJECTIVES: To determine the incidence of primary graft failure (PGF) following lung transplantation, assess possible risk factors, and characterize its effect on outcomes. METHODS: Retrospective review of 100 consecutive patients undergoing lung transplantation at the University of Pennsylvania Medical Center. Fifteen patients meeting diagnostic criteria for PGF (PGF+ group) were compared with 85 patients without this complication (PGF- group). RESULTS: The incidence of PGF was 15%. There was no significant difference in age, sex, underlying pulmonary disease, preoperative pulmonary artery systolic pressure, type of transplant, allograft ischemic times, use of cardiopulmonary bypass, or use of postoperative prostaglandin E1 infusion between the PGF+ and PGF- groups. Induction therapy with antilymphocyte globulin was used less frequently in the PGF+ group (p<0.005). Duration of mechanical ventilatory support was 36+/-43 days vs 4+/-6 days for the PGF+ and PGF- groups, respectively (p<0.0001). Hospital stay was significantly longer in the PGF+ group, averaging 75+/-105 days, compared with 27+/-38 days in the PGF group (p<0.005). One-year actuarial survival for the PGF+ group was only 40% compared with 69% for the PGF- group (p<0.005). Five of the six PGF+ survivors were ambulatory by 1 year; three were completely independent while two continued to require assistance with activities of daily living. Six-minute walk test distance among the ambulatory patients averaged 883+/-463 feet (range, 200 to 1,223 feet) compared with 1513+/-424 feet for the PGF- group (p<0.005). Among the subset of survivors who underwent single lung transplantation for COPD, the mean percent predicted FEV1 at 1 year was 43% for the PGF+ group and 55% for the PGF- groups, but this difference was not statistically significant. CONCLUSIONS: PGF is a devastating postoperative complication, occurring in 15% of patients in the current series, and it is associated with a high mortality rate, lengthy hospitalization, and protracted and often compromised recovery among survivors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yousem, S. A., Berry, G. J., Cagle, P. T., Chamberlain, D. W., Husain, A. N., Hruban, R. H., Marchevsky, A. M., Ohori, N. P., Ritter, J. M., Stewart, S., et al. (1996) · PubMed · Cited by 842
The Acute Respiratory Distress Syndrome
Kollef, M. H., & Schuster, D. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501053320106 · Cited by 550
Trulock, E. P. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.3.9117010 · Cited by 458
Inhaled nitric oxide reduces human lung allograft dysfunction
Date, H., Triantafillou, A. N., Trulock, E. P., Pohl, M. S., Cooper, J. D., & Patterson, G. A. (1996) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70364-1 · Cited by 236
Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation
Adatia, I., Lillehei, C., Arnold, J. H., Thompson, J. E., Palazzo, R., Fackler, J. C., & Wessel, D. L. (1994) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)91382-x · Cited by 193
Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation
Aeba, R., Griffith, B. P., Kormos, R. L., Armitage, J. M., Gasior, T. A., Fuhrman, C. R., Yousem, S. A., & Hardesty, R. L. (1994) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)90573-8 · Cited by 128
Hyperacute Rejection Following Lung Transplantation
Frost, A., Jammal, C. T., & Cagle, P. T. (1996) · CHEST Journal · doi:10.1378/chest.110.2.559 · Cited by 116
Reperfusion injury in single-lung transplant recipients with pulmonary hypertension and emphysema.
Boujoukos, A. J., Martich, G. D., Vega, J. D., Keenan, R. J., & GRIFFITH, B. P. (1997) · PubMed · Cited by 65
Redo lung transplantation: a North American-European experience.
Novick, R. J., Kaye, M. P., Patterson, G. A., Andréassian, B., Klepetko, W., Menkis, A. H., & McKenzie, F. (1993) · PubMed · Cited by 57
Early Lung Allograft Function in Twin Recipients From the Same Donor: Risk Factor Analysis
Sommers, K. E., Griffith, B. P., Hardesty, R. L., & Keenan, R. J. (1996) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(96)00371-2 · Cited by 55
Cited by
Ischemia–Reperfusion–induced Lung Injury
de Perrot, M., Liu, M., Waddell, T. K., & Keshavjee, S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-670so · Cited by 962
Christie, J. D., Carby, M., Bag, R., Corris, P., Hertz, M., & Weill, D. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.11.049 · Cited by 762
Self-citationArcasoy, S. M., & Kotloff, R. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904083401406 · Cited by 443
Self-citationPulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation
Kotloff, R. M., Ahya, V. N., & Crawford, S. W. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200309-1322so · Cited by 365
Self-citationThe Effect of Primary Graft Dysfunction on Survival after Lung Transplantation
Christie, J. D., Kotloff, R. M., Ahya, V. N., Tino, G., Pochettino, A., Gaughan, C., DeMissie, E., & Kimmel, S. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1243oc · Cited by 351
Self-citationTime-dependent bias was common in survival analyses published in leading clinical journals
van Walraven, C., Davis, D., Forster, A. J., & Wells, G. A. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.12.008 · Cited by 337
“5%] of those with a “baseline-immeasurable” time-dependent variable) of possible time-dependent bias because it was highly improbable or impossible for patients to experience an outcome prior to the time-dependent variable status being determined [15–40].”
BackgroundClinical Risk Factors for Primary Graft Failure Following Lung Transplantation
Christie, J. D., Kotloff, R. M., Pochettino, A., Arcasoy, S. M., Rosengard, B. R., Landis, J. R., & Kimmel, S. E. (2003) · Chest · doi:10.1378/chest.124.4.1232 · Cited by 275
Self-citationInterleukin-8 Release during Early Reperfusion Predicts Graft Function in Human Lung Transplantation
DE PERROT, M., SEKINE, Y., FISCHER, S., WADDELL, T. K., McRAE, K., LIU, M., WIGLE, D. A., & KESHAVJEE, S. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.2011151 · Cited by 268
Primary Graft Dysfunction and Long-term Pulmonary Function After Lung Transplantation
Whitson, B. A., Prekker, M. E., Herrington, C. S., Whelan, T. P. M., Radosevich, D. M., Hertz, M. I., & Dahlberg, P. S. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.07.018 · Cited by 265
Kotloff, R. M., & Thabut, G. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0134ci · Cited by 257
Self-citationRisk factors for early primary graft dysfunction after lung transplantation: a registry study
Kuntz, C. L., Hadjiliadis, D., Ahya, V. N., Kotloff, R. M., Pochettino, A., Lewis, J., & Christie, J. D. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2008.00951.x · Cited by 138
“While there is a spectrum of injury, the incidence of severe PGD ranges from 10 to 20% (1, 2, 3), with considerable impact on morbidity, early mortality, and long-term survival (1–9).”
BackgroundSelf-citation
Metadata
- Authors
- Christie, J. D., Bavaria, J. E., Palevsky, H. I., Litzky, L., Blumenthal, N. P., Kaiser, L. R., & Kotloff, R. M.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1998-07
- Volume
- 114
- Issue
- 1
- Pages
- 51-60
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2146102937
- Cited by
- 329
- References
- 13
- FWCI
- 14.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.